Skip to main content

Board of Directors

Meet the Board

Meet the Biocom Board of Directors, working to ensure Biocom’s programs, initiatives, and strategies work to accelerate life science across California.

“It’s so rewarding to see the tremendous impact the board has on advancing Biocom’s key initiatives and, through that, invigorating the entire Southern California life science community.””
Carin Canale, CEO, Canale Communications
“As past Chairman and current Board member of Biocom, I am thrilled that this organization continues to have such an impactful role in building the Life Science industry in California and in doing so contributes in a big way to the innovation economy. On a personal note, I treasure the time I spend on this dedicated Board with so many passionate and innovative leaders of this great industry.”
Magda Marquet, Co-Chairman & Founder, Althea

Executive Committee

Dan Burgess
Chair Emeritus; Chairman, Nabriva Therapeutics, PLC
Dan Burgess
Chair Emeritus; Chairman, Nabriva Therapeutics, PLC
Carin Canale-Theakston
Vice Chair; CEO, Canale Communications
Carin Canale-Theakston
Vice Chair; CEO, Canale Communications
Christophe Schilling, Ph.D.
Chairman; CEO, Genomatica, Inc.
Christophe Schilling, Ph.D.
Chairman; CEO, Genomatica, Inc.
Lisa Haile, J.D., Ph.D.
Vice President and General Counsel; Partner & Global Life Science Sector Chair, DLA Piper
Lisa Haile, J.D., Ph.D.
Vice President and General Counsel; Partner & Global Life Science Sector Chair, DLA Piper
Richard Pascoe
Chair Elect; CEO, Histogen
Richard Pascoe
Chair Elect; CEO, Histogen
Dan Kleeburg
Vice President, Finance; Partner, Ernst & Young LLP
Dan Kleeburg
Vice President, Finance; Partner, Ernst & Young LLP
Ted Schroeder
CEO, Nabriva Therapeutics
Ted Schroeder
CEO, Nabriva Therapeutics
Joseph Panetta
President and Chief Executive Officer, Member, Biocom Board of Directors
Joseph Panetta
President and Chief Executive Officer, Member, Biocom Board of Directors — San Diego

As the leading advocate for the life science industry in California, President and CEO Joe Panetta guides a robust organization of nearly 1000 members, setting strategic direction, guiding policy priorities, and championing the biopharmaceutical industry at the local, state, national, and international level.

Mr. Panetta holds a Bachelor of Science degree in biology from LeMoyne College, and a Master of Public Health degree in industrial and environmental health from the University of Pittsburgh. He is a graduate of the Brookings Institution Program for Executives and the Harvard Program on Negotiation.

Personal Interests:

  • Travel
  • Skiing
  • Piano
Ranjeet Banerjee
Worldwide President of Medication Management Solutions, BD
Ranjeet Banerjee
Worldwide President of Medication Management Solutions, BD
Jennifer Cayer
President & CEO, 3E Therapeutics
Jennifer Cayer
President & CEO, 3E Therapeutics
Charles Dadswell
Sr. VP & General Counsel, Illumina
Charles Dadswell
Sr. VP & General Counsel, Illumina
David Enloe
President and CEO of Ajinomoto Bio-Pharma Services
David Enloe
President and CEO of Ajinomoto Bio-Pharma Services
Stephen Ferruolo, J.D., Ph.D.
VP, Secretary; Dean & Professor of Law, USD School of Law
Stephen Ferruolo, J.D., Ph.D.
VP, Secretary; Dean & Professor of Law, USD School of Law
Wain Fishburn
Partner, Cooley
Wain Fishburn
Partner, Cooley
Wolfgang Glaesner, Ph.D.
CSO-AME, Eli Lilly & Company
Wolfgang Glaesner, Ph.D.
CSO-AME, Eli Lilly & Company
Steve Pacelli
EVP, Strategy & Corporate Affairs, DexCom
Steve Pacelli
EVP, Strategy & Corporate Affairs, DexCom
Trindl Reeves
Chief Sales Officer
Trindl Reeves
Chief Sales Officer
Timothy Scott
VP, Industry; CEO, TEGA Therapeutics
Timothy Scott
VP, Industry; CEO, TEGA Therapeutics
Peter Silvester
Senior Vice President, President of Life Sciences Solutions, Thermo Fisher Scientific
Peter Silvester
Senior Vice President, President of Life Sciences Solutions, Thermo Fisher Scientific
Lesley Stolz, Ph.D.
Head, JLABS California
Lesley Stolz, Ph.D.
Head, JLABS California

Board of Directors

Steven Bartz, Ph.D.
Executive Director, Business Development and Licensing, West Coast, Merck Research Labs
Steven Bartz, Ph.D.
Executive Director, Business Development and Licensing, West Coast, Merck Research Labs
Rick Bregman
San Diego Market President and National Co-Head of Bank of America’s Healthcare Banking Group
Rick Bregman
San Diego Market President and National Co-Head of Bank of America’s Healthcare Banking Group
Bruno Buisson, Ph.D.
CEO, Neuroservice
Bruno Buisson, Ph.D.
CEO, Neuroservice
Deanne Calvert, J.D.
Head, State Government Relations, Sanofi US
Deanne Calvert, J.D.
Head, State Government Relations, Sanofi US
Ho Cho, Ph.D.
Vice President, Biotherapeutics, Celgene
Ho Cho, Ph.D.
Vice President, Biotherapeutics, Celgene
Taylor Crouch
President & CEO, Organovo
Taylor Crouch
President & CEO, Organovo
Bassil Dahiyat, PhD.
President and CEO, Xencor
Bassil Dahiyat, PhD.
President and CEO, Xencor
Nazeli Dertsakian
VP & General Manager of Product Operations, Genentech
Nazeli Dertsakian
VP & General Manager of Product Operations, Genentech
Kelly Farrell
Chief of Staff, Sr. Director Oncology R&D, Pfizer
Kelly Farrell
Chief of Staff, Sr. Director Oncology R&D, Pfizer
Michael Farrington
Vice President Global Marketing, NuVasive
Michael Farrington
Vice President Global Marketing, NuVasive
Oliver Fetzer, Ph.D.
CEO, Synthetic Genomics
Oliver Fetzer, Ph.D.
CEO, Synthetic Genomics
Jack Florio
Managing Director, Objective Capital Partners
Jack Florio
Managing Director, Objective Capital Partners
Gregory Frost, Ph.D.
CEO, F1 Bio Ventures
Gregory Frost, Ph.D.
CEO, F1 Bio Ventures
Jeffrey W. Guise Ph.D. Esq.
Member, Wilson, Sonsini, Goodrich & Rosati
Jeffrey W. Guise Ph.D. Esq.
Member, Wilson, Sonsini, Goodrich & Rosati
Ronnie Hanecak, Ph.D.
Senior Director, Licensing, UC Irvine Applied Innovations
Ronnie Hanecak, Ph.D.
Senior Director, Licensing, UC Irvine Applied Innovations
Rachel Haurwitz, Ph.D.
President and CEO, Caribou Biosciences
Rachel Haurwitz, Ph.D.
President and CEO, Caribou Biosciences

Rachel is a co-founder of Caribou Biosciences and has been President and CEO since its inception in 2011. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. In 2018, the Association for Women in Science recognized Rachel with the annual Next Generation Award. Rachel is an inventor on several patents and patent applications covering multiple CRISPR-based technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. Rachel earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.

Richard Heyman, Ph.D.
Executive Chairman, Metacrine
Richard Heyman, Ph.D.
Executive Chairman, Metacrine
Ted Jacobs
Executive Managing Director, Cushman Wakefield
Ted Jacobs
Executive Managing Director, Cushman Wakefield
Gerald Joyce, M.D., Ph.D.
Institute Director, Genomics Institute of the Novartis Research Foundation
Gerald Joyce, M.D., Ph.D.
Institute Director, Genomics Institute of the Novartis Research Foundation
David Kabakoff, Ph.D.
Executive Partner, Private Equity, Sofinnova
David Kabakoff, Ph.D.
Executive Partner, Private Equity, Sofinnova
Katherine Kantardjieff, Ph.D.
Dean, College of Science and Mathematics, California State University San Marcos
Katherine Kantardjieff, Ph.D.
Dean, College of Science and Mathematics, California State University San Marcos
Steve Kay, Ph.D.
Provost Professor of Neurology, Biomedical Engineering and Biological Sciences Director of Convergent Bioscience, USC
Steve Kay, Ph.D.
Provost Professor of Neurology, Biomedical Engineering and Biological Sciences Director of Convergent Bioscience, USC
Paul Laikind, Ph.D.
President & CEO, ViaCyte
Paul Laikind, Ph.D.
President & CEO, ViaCyte
Cheston Larson, J.D.
Partner & Co-Chair Ð Life Sciences Industry Group, Latham & Watkins LLP
Cheston Larson, J.D.
Partner & Co-Chair Ð Life Sciences Industry Group, Latham & Watkins LLP
Andrew Lukowiak, Ph.D.
CEO, Millennium Health
Andrew Lukowiak, Ph.D.
CEO, Millennium Health
James Mackay, Ph.D.
CEO, Aristea Therapeutics
James Mackay, Ph.D.
CEO, Aristea Therapeutics
Stanley Maloy, Ph.D.
Associate Vice President for Research & Innovation, SDSU
Stanley Maloy, Ph.D.
Associate Vice President for Research & Innovation, SDSU
Damien McDevitt, Ph.D.
Chief Business Officer
Damien McDevitt, Ph.D.
Chief Business Officer
Marc T. Morley, J.D.
Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
Marc T. Morley, J.D.
Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
Tracy Murphy
Executive Vice President, Life Science, Kilroy Realty
Tracy Murphy
Executive Vice President, Life Science, Kilroy Realty
Daniel J. Ryan
Executive Vice President, Alexandria Real Estate Equities
Daniel J. Ryan
Executive Vice President, Alexandria Real Estate Equities
Dean Samsvick
Partner, KPMG LLP
Dean Samsvick
Partner, KPMG LLP
Tsuneo Takahashi
President, NF Corporation
Tsuneo Takahashi
President, NF Corporation
Kevin Tremblay
Sr. Director, SD Market Leader, Biomed Realty
Kevin Tremblay
Sr. Director, SD Market Leader, Biomed Realty
Tamera Weisser, Ph.D., J.D.
Partner, Jones Day
Tamera Weisser, Ph.D., J.D.
Partner, Jones Day
David Weitz
Head of Takeda California and Global Research Externalization, Takeda California, Inc.
David Weitz
Head of Takeda California and Global Research Externalization, Takeda California, Inc.
Ken Weixel
Managing Partner, San Diego, Deloitte & Touche LLP
Ken Weixel
Managing Partner, San Diego, Deloitte & Touche LLP
Tom West
Division President, Diagnostic Solutions, Hologic
Tom West
Division President, Diagnostic Solutions, Hologic

Life Directors

Ken Baldwin
Principal, Ferguson Pape Baldwin Architects
Ken Baldwin
Principal, Ferguson Pape Baldwin Architects
John Dunn
General Counsel, Vital Therapies
John Dunn
General Counsel, Vital Therapies
David Hale
Chairman, Hale BioPharma Ventures
David Hale
Chairman, Hale BioPharma Ventures
Guy Iannuzzi
CEO, Mentus
Guy Iannuzzi
CEO, Mentus
Brent Jacobs
Executive Managing Director, Cushman & Wakefield Global Life Sciences Practice Group
Brent Jacobs
Executive Managing Director, Cushman & Wakefield Global Life Sciences Practice Group
Jack Lief
Director, CeleCor
Jack Lief
Director, CeleCor
Magda Marquet, Ph.D.
Co-Chairman & Founder, Althea (a member of Ajinomoto Group)
Magda Marquet, Ph.D.
Co-Chairman & Founder, Althea (a member of Ajinomoto Group)
Steven Mento
President and CEO, Conatus Pharmaceuticals
Steven Mento
President and CEO, Conatus Pharmaceuticals
Tina Nova, Ph.D.
President and CEO, Molecular Stethoscope
Tina Nova, Ph.D.
President and CEO, Molecular Stethoscope
Larry Stambaugh
Chairman, Molecular Assemblies, Inc.
Larry Stambaugh
Chairman, Molecular Assemblies, Inc.

Ex-Officio

Sandra Brown, Ph.D.
Vice Chancellor for Research, UCSD
Sandra Brown, Ph.D.
Vice Chancellor for Research, UCSD
Mark Cafferty
President & CEO, SD Regional Economic Development Corp.
Mark Cafferty
President & CEO, SD Regional Economic Development Corp.
Peter Callstrom
President & CEO, SD Workforce Partnership
Peter Callstrom
President & CEO, SD Workforce Partnership
Sunita Cooke, Ph.D.
Superintendent/President, Mira Costa College
Sunita Cooke, Ph.D.
Superintendent/President, Mira Costa College
Scott Lippman, Ph.D.
Scott Lippman, Ph.D.
Scott Lippman, Ph.D.
Scott Lippman, Ph.D.
Greg McKee
President & CEO
Greg McKee
President & CEO
Peter Preuss
President, The Preuss Foundation
Peter Preuss
President, The Preuss Foundation
Jerry Sanders
President & CEO, SD Regional Chamber of Commerce
Jerry Sanders
President & CEO, SD Regional Chamber of Commerce
David Webb, Ph.D.
Adjunct Professor, Scripps Research Institute
David Webb, Ph.D.
Adjunct Professor, Scripps Research Institute